GE HealthCare Technologies Inc (GEHC)

NASDAQ
Currency in USD
Disclaimer
80.44
-0.51(-0.63%)
Closed
After Hours
81.62+1.18(+1.47%)
GEHC Scorecard
Full Analysis
Prominent player in the Healthcare Equipment & Supplies industry
Fair Value
Day's Range
79.9181.39
52 wk Range
62.3594.50
Prev. Close
80.95
Open
81.23
Day's Range
79.91-81.39
52 wk Range
62.35-94.5
Volume
2,428,375
Average Volume (3m)
2,768,314
1-Year Change
-2.65%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
GEHC Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
92.52
Upside
+15.02%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts predict the company will be profitable this year

Compare GEHC to Peers and Sector

Metrics to compare
GEHC
Peers
Sector
Relationship
P/E Ratio
23.3x32.5x−0.6x
PEG Ratio
−2.620.510.00
Price/Book
5.0x2.4x2.6x
Price / LTM Sales
1.9x2.5x3.1x
Upside (Analyst Target)
14.4%55.0%57.7%
Fair Value Upside
Unlock−1.8%8.9%Unlock

People Also Watch

107.81
PCAR
-1.97%
81.80
APP
+1.08%
111.66
DXCM
+0.87%
189.30
CEG
+1.08%
74.33
CTSH
-2.16%

GE HealthCare Technologies Inc Company Profile

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women’s health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women’s health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.